NCT06973499Completed
Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer
Source: ClinicalTrials.gov · Last updated 15 May 2025
Brief summary (registry, in English)
This is an exploratory, single-center, being conducted at Beijing Haidian Hospital in order to detect the relationship between microbiome of upper gastrointestinal and pathogenesis of multiple primary lung cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 20 (actual)
- First submitted
- 25 Jun 2022
- Start date
- 6 Jan 2023
- Primary completion date
- 30 May 2024
- Lead sponsor
- Beijing Haidian Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06973499
What you commit to
- Study type: Observational
- Participants enrolled: 20
- From 6 Jan 2023 to the primary completion date, 30 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Preoperative examination of patients who cannot tolerate surgical resection
- Patients who received antibiotics within 1 week before surgery E) Resected multiple pulmonary nodules with pathologically proven lung cancer of less than 2 patients
Other illness
- severe heart, liver, brain, kidney and other important organ diseases and bone marrow hematopoietic dysfunction;
- Multiple nodules resected were confirmed to be metastases, not primary lung cancer
Age
- under 18 years of age (excluding 18 years of age, male or female) or unwilling to sign informed consent;
Who the study is looking for
- At least 18 years of age (including 18 years of age, male or female) and voluntarily signed informed consent;
- Chest CT imaging showed at least 2 pulmonary nodules with a diameter of less than 3cm in ipsilateral lung, and imaging diagnosis of highly suspicious multiple primary lung cancer
- No surgical contraindication, surgical resection is feasible, and postoperative pathology is diagnosed as multiple primary lung cancer according to Martini and Melamed criteria and gene testing
- The amount of at least 2 or more tissues removed from multiple pulmonary nodules must meet the requirements of pathological diagnosis, molecular detection and microflora detection
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Haidian Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.